Pharmacodynamic biomarkers of anti-NRP1 activity in phase I, dose-escalating clinical trials as a single agent and combined with bevacizumab

Abstract only

Saved in:

Bibliographic Details
Published in	Journal of clinical oncology Vol. 28; no. 15_suppl; p. e13551
Main Authors	Yan, Y., Li, J., Wu, J., Xin, Y., Aimi, J., Xiang, H., Bagri, A., Brachmann, R. K., Chen, D. S., Hegde, P.
Format	Journal Article
Language	English
Published	20.05.2010
Online Access	Get full text

Loading…